Gene expression signature in peripheral blood detects thoracic aortic aneurysm

PLoS ONE

Volumn 2, Issue 10, 2007, Pages

  Wang, Yulei ^a   Barbacioru, Catalin C ^a   Shiffman, Dov ^b   Balasubramanian, Sriram ^b,c   Iakoubova, Olga ^b   Tranquilli, Maryann ^d   Albornoz, Gonzalo ^d   Blake, Julie ^a   Mehmet, Necip N ^a   Ngadimo, Dewi ^b,c   Poulter, Karen ^a   Chan, Frances ^a   Samaha, Raymond R ^a   Elefteriades, John A ^d  

^a APPLIED BIOSYSTEMS   (United States)

^b CELERA   (United States)

^c PHARMACYCLICS INC   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ASCENDING AORTA; BLOOD SAMPLING; CLASSIFIER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DESCENDING AORTA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FAMILIAL DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NUCLEAR MAGNETIC RESONANCE IMAGING; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; THORACIC AORTA ANEURYSM; VALIDATION PROCESS; BLOOD; CASE CONTROL STUDY; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOME; LABORATORY DIAGNOSIS; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

AORTIC ANEURYSM, THORACIC; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FALSE POSITIVE REACTIONS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 39749125027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001050     Document Type: Article

References (50)

1. Coady MA, Rizzo JA, Hammond GL, Mandapati D, Darr U, et al. (1997) What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 113: 476-491; discussion 489-491.
2. Dapunt OE, Midulla PS, Sadeghi AM, Mezrow CK, Wolfe D, et al. (1994) Pathogenesis ofspinal cord injury during simulated aneurysm repair in a chronic anitnal model. Ann Thorac Surg 58: 689-696; discussion 696-687.
3. Mandel M, Gurevich M, Pauzner R, Kaminski N, Achiron A (2004) Autoinummity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus crythematasus. Clin Exp Immunol 138: 164-170.
4. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100: 2610-2615.
5. Batliwalla FM, Baechler EC, Xiao X, Li W, Balasubramanian S, et al. (2005) Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun 6: 388-397.
6. Achiron A, Gurevich M, Magalashvili D, Kishner I, Dolev M, et al. (2004) Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathways. Clin Dev Immunol 11: 299-305.
7. Achiron A, Gurevich M, Friedman N, Kaminski N, Mandel M (2004) Blood transcriptional signatures ofmultiple sclerosis: unique gene expression ofdisease activity. Ann Neurol 55: 410-417.
8. Bomprezzi R, Ringner M, Kim S, Bittner ML, Khan J, et al. (2003) Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet 12: 2191-2199.
9. Baranzini SE, Mousavi P, Rio J, Caillier SJ, Stillman A, et al. (2005) Transcription-based prediction of response to IFNbeta using supervised computational methods. PLoS Biol 3: e2.
10. Patino WD, Mian OY, Kang JG, Matoba Si Bartlett LD, et al. (2005) Circulating transcriptome reveals markers of atherosclerosis. Proc Natl Acad Sci U S A 102: 3423-3428.
11. Ma J. Liew CC (2003) Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol 35: 993-998.
12. Chittenden TW, Sherman JA, Xiong F, Hall AE, Lanahan AA, et al. (2006) Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation: 114: 1811-1820.
13. Timofeeva AV, Goryunova LE, Khaspekov GL, Kovalevskii DA, Scamrov AV, et al. (2GO6) Altered gene expression pattern in peripheral blood leukocytes from patients with arterial hypertension. Ann N Y Acad Sci 1091: 319-335.
14. Guo D, Hasham S, Kuang SQ Vaughan CJ, Boerwinkle E, et al. (2001) Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103: 2461-2468.
15. Hasham SN, Willing MC, Guo DC, Muilenburg A, He R, et al. (2003) Mapping a locus for familial thoracic aortic aneurysms and dissections (TAAD2) to 3p24-25. Circulation 107: 3184-3190.
16. Khan Van Kien P, Mathieu F, Zhu L, Lalande A, Betard C, et al. (2005) Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. Circulation 112: 200-206.
17. Wung SF, Aouizerat BE (2004) Newly mapped gene for thoracic aortic aneurysm and dissection. J Cardiovasc Nurs 19: 409-416.
18. Tang PC, Yakimov AO, Teesdale MA, Coady MA, Dardik A, et al. (2005) Transmural inflammation by interferon-gamma-producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms. Faseb J 19: 1528-1530.
19. Koullias G, Modak R, Tranquilli M, Korkolis DP, Barash P, et al. (2005) Mechanical deterioration underlies malignant behavior of ancurysmal human ascending aorta. J Thorac Cardiovasc Surg 130: 677 e671-672.
20. Koullias QJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA (2004) Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 78: 2106-2110; discussion 2110-2101.
21. Walton LJ, Franklin U, Bayston T, Brown LC, Greenhalgh RM, et al. (1999) Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 100: 48-54.
22. Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Halloran BG, et al. (2001) Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res 101: 152-156.
23. Ocana E, Bohorquez JC, Perez-Requena J, Brieva JA, Rodriguez C (2003) Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis 170: 39-48.
24. Schonbeck U, Sukhova GY, Gerdes N, Libby P (2002) T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol 161: 499-506.
25. Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, et al. (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7: 127.
26. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121.
27. Mi H, Lazareva-Ulitsky B, Lou R, Kejariwal A, Vandergriff J, et al. (2005) The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33: D284-288.
28. Cho RJ, Campbell MJ (2000) Transcription, genomes, function. Trends Genet 16: 409-415.
29. Efron B, Tibshirani FJ (1993) An Introduction to the Bootstrap.
30. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids ofgene expression. Proc Natl Acad Sci U S A 99:6567-6572.
31. Albornoz G, Coady MA, Roberts M, Davies RR, Tranquilli M, et al. (2006) Familial thoracic aortic aneurysms and dissections-incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg 82: 1400-1405.
32. Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, et al. (1999) Familial patterns of thoracic aortic aneurysms. Arch Surg 134: 361-367.
33. Hasham SN, Lewin MR, Tran VT, Pannu H, Muilenburg A, et al. (2004) Nonsyndromic genetic predisposition to aortic dissection: a newly recognized, diagnosable, and preventable occurrence in families. Ann Emerg Med 43: 79-82.
34. Kakko S, Raisanen T, Tamminen M, Airakainen J, Groundstroem K, et al. (2003) Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5q13-14 in Finnish families. J Thorac Cardiovasc Surg 126: 106-113.
35. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, et al. (1999) Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99: 96-104.
36. Dawson J, Cockerill GW, Choke E, Belli AM, Loflus I, et al. (2007) Aortic aneurysms secrete interleukin-6 into the circulation. J Vasc Surg 45: 350-356.
37. Shimizu K, Mitchell RN, Libby P (2006) Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26: 987-994.
38. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN (2004) Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest 114: 300-308.
39. Middleton RK, Lloyd GM, Bown MJ, Cooper M, London NJ, et al. (2007) The pro-inflammatory and chemotactic cytokine microenviromnent of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg 45: 574-580.
40. Xiong W, Knispel R, Mactaggart J, Baxter BT (2006) Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation. J Vasc Surg 44: 1061-1066.
41. Pinderski Oslund LJ, Hedrick CC, Olvera T, Hagenbaugh A, Territo M, et al. (1999) Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vase Biol 19: 2847-2853.
42. Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, et al. (1996) Cross-regulatory rules of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97: 2130-2138.
43. Huber TS, Gaines GC, Welborn MB 3rd, Rosenberg JJ, Seeger JM, et al. (2000) Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. Shock 13: 425-434.
44. Curci JA, Thompson RW (2004) Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? J Clin Invest 114: 168-171.
45. Ivanov VN, Krasilnikov M, Ronai Z (2002) Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinasc-AKT signaling. J Biol Chem 277: 4932-4944.
46. Suhara T, Kim HS, Kirshenbaum LA, Walsh K (2002) Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation. Mol Cell Biol 22: 680-691.
47. Lin CL, Winardi W, Jeng AY, Kwan AL (2006) Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm. Neurol Res 28: 721-729.
48. Pan JH, Lindholt JS, Sukhova GK, Baugh JA, Henneberg EW, et al. (2003) Macrophage migration, inhibitory factor is associated with aneurysmal expansion. J Vasc Surg 37: 628-635.
49. Verschuren L, Lindeman JH, van Bockel JH, Abdul-Hussien H, Kooistra T, et al. (2005) Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms. Antioxid Redox Signal 7: 1195-1202.
50. Elefteriades JA (2007) Natural history: Evidence-based indications for operation. Surgery of the Aortic Arch In, Coselli J (ed).